Sean Peel (Ph.D.) Email & Phone Number

A life sciences executive with 20 years’ experience building and leading teams in clinical product development and in both start-up and established organizations.After obtaining my Ph.D. in Oral Biology, I performed postdoctoral research in tissue engineering. I then joined GenSci Regeneration Sciences Inc where I was responsible for the evaluation of various tissue-based devices for bone repair. During this time I spent a year at UCLA working on bone morphogenetic proteins (BMPs).I continued this work at the University of Toronto before being recruited to Osteopharm Inc. where I lead a team of 4 scientists and technicians and managed both the in-house and external preclinical development of a peptide therapeutic. I was also responsible for establishing a diagnostics program. I then worked as a consultant managing various projects including technical due diligence covering areas of product development, clinical strategy, and market potential, managing research projects and decommissioning a research facility.In 2008 I cofounded Induce Biologics Inc, serving as CSO, managing the development, early stage manufacturing and non clinical testing of growth factor based bioimplants for tissue regeneration.In 2017 I joined OBIO to start their Health to Business Bridge internship program, which helps companies source, train and mentor business trained interns and recent graduates.In 2020 I joined Red Rock Regeneration Inc. as CSO managing the non-clinical and clinical testing and manufacturing of a growth factor based bioimplant.I am also an Assistant Professor (status only) in Oral Surgery and a member of the School of Graduate Studies at the University of Toronto, where I have supervised 10 MSc and 2 PhD students. I have authored or co-authored over 40 research articles and 4 book chapters and am an inventor on 8 families of patents (5 of the families have patents granted in various countries).

Listed skills include Biotechnology, Medical Devices, Cell, Regenerative Medicine, and 33 others.